PYCR1 and non-small cell lung carcinoma: Among the 42 patients with NSCLC, PYCR1 expression was upregulated in 29 patients (69%) and downregulated in 13 patients (31%) (Fig. 1a), with a significant ΔMag difference between the PYCR1up and PYCR1down groups (Fig. 1b).